Research programme: serotonin 1A receptor inverse agonists - RecordatiAlternative Names: REC-27/0074; REC-27/0224
Latest Information Update: 28 Apr 2009
At a glance
- Originator Recordati
- Mechanism of Action Serotonin 1A receptor inverse agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 28 Apr 2009 No development reported - Preclinical for Depression in Italy (unspecified route)
- 12 Jun 2006 Preclinical trials in Depression in Italy (unspecified route)